Navigation Links
Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines

Oncolytics, please visit www.oncolyticsbiotech.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the implication of the materials presented at this conference with respect to REOLYSIN(R), the Company's expectations related to the results of trials investigating delivery of REOLYSIN(R), and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements.

CONTACT: Oncolytics Biotech Inc., Cathy Ward, 210, 1167 Kensington Cr NW,Calgary, Alberta, T2N 1X7, Tel: (403) 670-7377, Fax: (403) 283-0858,; The Equicom Group, Nick Hurst, 325, 300 5th AveSW, Calgary, Alberta, T2P 3C4, Tel: (403) 538-4845, Fax: (403) 237-6916,; The Investor Relations Group, Erika Moran, 11Stone St, 3rd Floor, New York, NY, 10004, Tel: (212) 825-3210, Fax: (212)825-3229,




Page: 1 2 3

Related medicine technology :

1. Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S. Phase I REOLYSIN Trial
2. Oncolytics Biotech Inc.s Research Collaborators to Present REOLYSIN Clinical Trial Data at ASCO Conference
3. Oncolytics Biotech Inc. Collaborators to Present Reovirus/Gemcitabine Combination Research at AACR Annual Meeting
4. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
5. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
8. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
9. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
10. New Positive Pre-clinical Data for Active Biotechs RA Project I-3D
11. Prana Biotechnology Presents New Key Findings on PBT2
Post Your Comments:
(Date:10/10/2008)...0 /- Inverness Medical,Inno... near-patient,diagnostics, monitoring and health m...n, the Secretary-General of the United Nations, as... of the world,s leading,research-based and generic...s, together with senior officials from the United ...
(Date:10/9/2008)...reased Sales and Marketing Efforts to Accelerate ...tem, MENLO PARK, Calif., Oct. 9 /- E...ces for the percutaneous repair of cardiac valves,...am with the appointment of,Sean Cleary as senior v...,Chris Richardson, as vice president of sales., "...
(Date:10/8/2008)... Animal Use in Cosmetics and Chemicals Testing, A... today announced,that results of a recently comple...lidation study on MatTek,s EpiDerm in vitro human ...ted the required sensitivity and,specificity for E...o animal,testing for determining human skin irrita...
(Date:10/8/2008)...o evaluate TAXUS(R) Element(TM) Platinum Chromium ...ss., Oct. 8 /- Boston Scien...at it has completed enrollment in,the PERSEUS tria...tion,TAXUS(R) Element(TM) paclitaxel-eluting coron...ed nearly 1,500 patients at 100 U.S. and,internati...
Breaking Medicine Technology:Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Best Practice Database Supports Bio Pharma M 26A Integration with New Publication 21393 1Best Practice Database Supports Bio Pharma M 26A Integration with New Publication 21393 2Golf cart injuries on the rise 21391 1Golf cart injuries on the rise 21391 2Video 3A The Nevada Division of Insurance Launches 2008 Health Sham Insurance Campaign 21390 1Video 3A The Nevada Division of Insurance Launches 2008 Health Sham Insurance Campaign 21390 2Video 3A The Nevada Division of Insurance Launches 2008 Health Sham Insurance Campaign 21390 3N Y Mets Omar Minaya Recognized at National Brain Cancer Organizations 3rd Annual Gala 21385 1N Y Mets Omar Minaya Recognized at National Brain Cancer Organizations 3rd Annual Gala 21385 2
...ion Pharmaceuticals Inc.,(TSX: TLN) announced toda...al trial investigating ECO-4601 in advanced cancer...f the American,Society of Clinical Oncology (ASCO)... I dose escalation portion of the study, 14,patien...one,glioma), that had completed and not responded ...
...- Imprime PGG(TM), an,investigational new drug fro...response, increases the effectiveness of Avastin(R... new preclinical,research presented yesterday at t...al Meeting in Chicago., Researchers at the Brown C...studied the synergistic effects of Imprime,PGG in ...
Other Medicine Technology:Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 2Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 3Biothera's Imprime PGG Enhanced Effectiveness of Avastin in Cancer,Study 2
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...e of the African naked mole-rat is helping scienti...in humans. Mole-rats are blind, hairless, and li...led over by a queen. In a new study, scientists, ...atures, are hoping to learn more about how stress ...
...ened to nationalise private hospitals if their own... a nationally televised speech, saying that the pr...part of the public health service if they failed t...e also described costs at private clinics as a sym...
... the knot-like structure of enzymes, but theyve be... an understanding of function what the enzyme act...drug discovery, since many of the most successful .... Now, in an expedited article in NATURE, research...
...ped by methane gas is commonplace in developing co... West too. Fiver persons fell victims to the deadl...arm in Shenandoah Valley, Virginia, US Monday even...34, a Mennonite farmer who climbed into the pit to...
Other Medicine News:Health News:Strange Sex Life of Mole-rats may Provide Clues About Human Infertility 2Health News:Translating Structure into Function 2Health News:Five Killed by Methane Gas on Virginia Farm 2Health News:Five Killed by Methane Gas on Virginia Farm 3
The Affinity pacemaker family offers some of today's smallest, truly automatic devices. Featuring the most effective combination of advanced technologies ever seen, the Affinity DR pacemaker incorpor
Innovative new tools for more efficient patient management begin when the pacemaker is implanted. These sophisticated tools are in effect each day, and they help automate follow-up tasks.
The first-ever completely automatic pacemaker, EnPulse offers exclusive features that make it sophisticated yet simple to use. It performs a wide range of diagnostic tests on a regular basis, without
...ystem 3000Dx (GCS3000Dx) is the first microarray i...oratories. The system consists of the FS450Dx Flui...g and staining of the array, the GCS3000Dx Scanner...croarrays to be scanned without operator intervent...
Medicine Products: